Azenta, Inc. (AZTA) Stock Price & Analysis
Azenta, Inc. (AZTA) rose 0.04% to USD 22.72 as of June 10, 2026 at 05:26 UTC, according to Nexqual real-time market data.
AZTA last closed at USD 22.71; the session ranged USD 22.25–23.41 on volume of 955,627 shares. Market capitalization is $1.05B, with a 52-week range of USD 15.93–41.73 (NMS). Source: Nexqual, June 10, 2026 at 05:26 UTC.
Key Statistics (as of June 10, 2026 at 05:26 UTC)
| Price | USD 22.72 |
|---|---|
| Change | ▲ 0.04% (up) |
| Previous Close | USD 22.71 |
| Open | USD 23.02 |
| Day Range | USD 22.25 – 23.41 |
| 52-Week Range | USD 15.93 – 41.73 |
| Volume | 955,627 shares |
| Market Cap | $1.05B |
| Exchange | NMS |
Technical Analysis (AZTA)
Nexqual's technical model rates AZTA "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 05:26 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 52.13 (neutral) |
| vs SMA50 | Above (USD 21.98) |
| MACD | 0.46 (positive) |
Analyst Ratings (AZTA)
Wall Street analysts rate AZTA "None" based on 5 analysts, with a mean price target of USD 26.2 (range USD 20–33), per Nexqual as of June 10, 2026 at 05:26 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 26.2 |
| High Target | USD 33 |
| Low Target | USD 20 |
| Buy / Hold / Sell | 3 / 3 / 0 |
Earnings (AZTA)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD 0.1 |
| Revenue Estimate | $149.28M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.04 vs est 0.14 ▼ miss |
| 2025-12-31 | USD 0.09 vs est 0.13 ▼ miss |
| 2025-09-30 | USD 0.21 vs est 0.2 ▲ beat |
| 2025-06-30 | USD 0.19 vs est 0.14 ▲ beat |
Source: Nexqual, June 10, 2026 at 05:26 UTC.
Financials & Fundamentals (AZTA)
| Total Revenue | $596.48M |
|---|---|
| Revenue Growth (YoY) | +1.00% |
| Gross Margin | +44.33% |
| Operating Margin | -10.56% |
| Profit Margin | -29.06% |
| ROE | -6.81% |
| Debt / Equity | 3.58 |
| Current Ratio | 2.83 |
| Total Cash | $380.52M |
| Total Debt | $55.71M |
| Free Cash Flow | $101.33M |
Source: Nexqual, June 10, 2026 at 05:26 UTC.
Financial Health Score (AZTA)
Nexqual rates Azenta, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:26 UTC.
| Growth | Weak — Revenue -10% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 44%, operating -11% |
| Balance Sheet | Strong — $381M cash vs $56M debt, net cash position |
| Cash Flow | Strong — FCF $101M, 17% margin |
| Efficiency | Critical — ROE -7%, ROA -0.6% |
Ownership (AZTA)
| Insider Ownership | +1.00% |
|---|---|
| Institutional Ownership | +119.79% |
| Shares Outstanding | 46.09M |
| Float | 40.60M |
| Short % of Float | +20.04% |
Source: Nexqual, June 10, 2026 at 05:26 UTC.
Leadership (AZTA)
Azenta, Inc. is led by John P. Marotta (age 44), President, CEO & Director, per Nexqual as of June 10, 2026 at 05:26 UTC.
| President, CEO & Director | John P. Marotta (age 44) |
|---|---|
| Executive VP & CFO | Lawrence Y. Lin (age 48) |
| Vice President of Financial Planning & Analysis and Investor Relations | Yvonne Perron |
| Senior Vice President & President of Multiomics | William E. Martin (age 50) |
| Vice President and General Manager of Sample Repository Solutions | Alex Esmon |
Major Backers & Investors (AZTA)
Notable institutional backers of Azenta, Inc. include Politan Capital Management LP, Conestoga Capital Advisors, LLC, Conestoga Funds-Conestoga Small Cap Fund, according to Nexqual as of June 10, 2026 at 05:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Politan Capital Management LP | 10.03% |
| Conestoga Capital Advisors, LLC | 6.17% |
| Conestoga Funds-Conestoga Small Cap Fund | 4.01% |
| Massachusetts Financial Services Co. | 3.88% |
| Allspring Global Investments Holdings, LLC | 3.5% |
| American Capital Management, Inc. | 2.81% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 22.1% |
| Vanguard Group | 16.73% |
| Dimensional Fund Advisors | 4.47% |
| State Street | 3.82% |
Source: Nexqual, June 10, 2026 at 05:26 UTC.
From Azenta, Inc.'s Latest SEC 10-K Filing (filed 2025-12-04)
Key Strengths & Strategy (as disclosed to the SEC)
- Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
- It operates through Sample Management Solutions and Multiomics segments.
- The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services.
- This segment also offers consultation services to clients throughout their experimental design and implementation processes.
Partnerships
- The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SHC | Sotera Health Company | USD 16.53 | ▲ 5.83% |
| STVN | Stevanato Group S.p.A. | USD 18.1 | ▼ 1.95% |
| PRVA | Privia Health Group, Inc. | USD 22.17 | ▲ 2.5% |
| RRX | Regal Rexnord Corporation | USD 213.3 | ▲ 4.35% |
| NVST | Envista Holdings Corporation | USD 24.59 | ▲ 6.45% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:26 UTC. This page is informational and not investment advice.